C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/62 (2006.01) A61K 38/28 (2006.01) C12N 15/17 (2006.01) C12N 15/63 (2006.01)
Patent
CA 2330183
The invention relates to insulin analogs exhibiting enhanced zinc binding capacity and to stable zinc complexes thereof having a retarded activity in comparison with human insulin. The invention further relates to a method for the production of said insulin analogs and to their use, particularly in pharmaceutical preparations for therapy of type I and type II diabetes mellitus.
L'invention concerne des analogues de l'insuline présentant un pouvoir de liaison accru avec le zinc. Elle concerne également des complexes zinc-analogues d'insuline stables qui présentent un profil d'activité retardé par rapport à l'insuline humaine. L'invention concerne en outre un procédé de production desdits analogues ainsi que l'utilisation de ces derniers notamment dans des préparations pharmaceutiques pour le traitement du diabète sucré de type I mais aussi de type II.
Ertl Johann
Geisen Karl
Habermann Paul
Seipke Gerhard
Wollmer Axel
Aventis Pharma Deutschland Gmbh
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Sanofi-Aventis Deutschland Gmbh
LandOfFree
Novel insulin analogs with enhanced zinc binding does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel insulin analogs with enhanced zinc binding, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel insulin analogs with enhanced zinc binding will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1927113